News & Views

Cancer research

Gene-Editing Tool May Better Deliver CAR T-Cell Immunotherapy

In mouse experiments, researchers have found that immune T cells that have been genetically engineered to express chimeric antigen receptors (CARs) using a new tool called CRISPR were more effective than CAR T cells that were engineered with conventional methods. The findings were reported in Nature.

Trending Topics

View All Topics

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Broadens Ceritinib Indication to Previously Untreated ALK-Positive Metastatic NSCLC

Accelerated Approval to Pembrolizumab

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pembrolizumab for First Tissue/Site Agnostic Indication

Recognize and Release Muscle Tension

Nurse self-care

Learn to Recognize and Release Muscle Tension

administering IV chemotherapy treatments

What Special Considerations Are Needed When Setting up IV Chemotherapy?

Chemical Coping

Pain management

When Ineffective Pain Control Means Chemical Coping

Telehealth

Clinical practice guidelines

Joint Commission Offers Telehealth Revisions to Hospital, Ambulatory Accreditation Standards

Oncology Nurse Navigator

Nurse navigator

Updated Competencies Outline Oncology Nurse Navigator Role From Novice to Expert

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Approval to Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma

Seborrheic Keratosis

Dermascopic Clues Help Identify Seborrheic Keratosis-Like Melanoma

Caring for Multiple Patients

Clinical practice

The Challenge of Caring for Multiple Patients With Cancer

Cancer Clinical Trials

Oncology clinical trials

How One Institution Improved Accrual to Cancer Clinical Trials

Opioids

Pain management

The Case of the Omitted Opioid

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pembrolizumab in Combination With Pemetrexed and Carboplatin for Treatment of Metastatic Non-Squamous NSCLC

Celebrate Nurses

Renew Your Mind, Body, and Spirit This May While Celebrating Nurses

Melanoma Survivors

10% of Melanoma Survivors Report Intentional Tanning

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Avelumab for Urothelial Carcinoma

CAR T-Cell Therapy

Nursing Considerations for Adverse Events From CAR T-Cell Therapy

ONS member programs

ONS Cultivates New and Sustaining Member Programs Throughout the Seasons

Online Tools to Create Survivorship Care Plans

Survivorship care plans

How Do You Use Free Online Tools to Create Survivorship Care Plans?

Lung Cancer Screening

High-Risk Lung Cancer Screening Rates Remain Low

Darcy Burbage

Coordinated care

Creating and Sustaining Survivorship Care Plans in Practice

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Durvalumab for Urothelial Carcinoma Treatment

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Brigatinib for ALK-Positive NSCLC

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Midostaurin for FLT3-Positive Adult AML, Advanced Systemic Mastocytosis

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Expands Regorafenib Indications for Patients with HCC

Fraudulent Cancer Treatments

U.S. Food and Drug Administration (FDA)

FDA Issues Warnings to Fraudulent Cancer Treatment Companies

Early-Stage Melanoma

Disease Symptoms Most Likely to Predict Recurrence of Early-Stage Melanoma

Standards of Care

How Do I Move Standards of Care Into Practice?

Safe Handling of Hazardous Drugs

What Are ONS’s Recommendations for Safe Handling of Hazardous Drugs?

Patient in Bed

Patients Treated for Early-Stage Breast Cancer Report Severe Side Effects

Immunotherapy Inquiry

The Case of the Immunotherapy Inquiry

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Marketing of First Digital Pathology Whole Slide Imaging System

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Removes Risk Evaluation Management Strategies (REMS) for ESAs

Prostate Screening

Prostate cancer

Revised USPSTF Draft Guidelines Recommend Individual Prostate Cancer Screening Decisions

Text Messaging

Secured Text Messaging Orders Declared Unacceptable by the Joint Commission

Nurses talking

Clinical practice

AJCC Cancer Staging System Will See Changes in 2018

Bortezomib May Improve Outcomes in Multiple Myeloma

Multiple myeloma

Bortezomib May Improve Outcomes in Multiple Myeloma

cancer research finds significant increase in survival rates

Annual Cancer Report Identifies Significant Increases in Survival

Immunotherapy Agents

What Oncology Nurses Need to Know About Immunotherapy Agents

Brenda Nevidjon

Serving on Boards Allows Nurses to Improve the Nation’s Health

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Marketing Ipsogen JAK2 RGQ PCR Kit to Help Evaluate Suspected Polycythemia Vera

Walking the dog

Cancer prevention

Physical Activity Benefits Patients and Nurses Throughout Life

Mindfulness Meditation

Mindfulness Meditation Can Improve Safety in Your Practice

Colorectal Cancer Rates in Younger Adults

Cancer research

Study Finds Increased Colorectal Cancer Rates in Younger Adults

Member Feedback

ONS’s 2017 Financial Priorities Are Based on Member Feedback

Heather Mackey

What Is ONS’s Process for Creating Oncology Nursing Competencies?

Nursing Competencies

Competencies Create Expert, Accountable Nurses Delivering Quality Care

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Broadens Palbociclib Indication in Breast Cancer

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Osimertinib for EGFR T790 Mutation-Positive NSCLC

Back to Top ▲